Method for preparing pregabalin intermediate (r)-3-(carbamoylmethyl)-5-methylhexanoic acid

US2021114970A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2021114970-A1
Application numberUS-202017112891-A
CountryUS
Kind codeA1
Filing dateDec 4, 2020
Priority dateJun 6, 2018
Publication dateApr 22, 2021
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method for preparing pregabalin chiral intermediate (R)-3-(carbamoylmethyl)-5-methylhexanoic acid by a biological enzyme method. In particular, the method comprises: reacting compound (I) 3-isobutylglutaric acid, as a raw material, with a nitrogen-containing agent to produce compound (II) 3-isobutylglutarimide; and performing stereoselective ring-opening of compound (II) under the action of a biological enzyme to produce compound (III) (R)-3 -(carbamoylmethyl)-5-methylhexanoic acid:

First claim

Opening claim text (preview).

1 . A method for preparing (R)-3-(carbamoylmethyl)-5-methylhexanoic acid comprising: reacting 3-isobutylglutaric acid with a nitrogen-containing reagent to produce 3-isobutylglutarimide; reacting the 3-isobutylglutarimide in a solvent with a biological enzyme to perform stereoselective ring-opening to produce (R)-3-(carbamoylmethyl)-5-methylhexanoic acid; wherein: the biological enzyme is a hydrolase. 2 . The method of claim 1 , wherein the hydrolase is a lipase or an esterase. 3 . The method of claim 2 , wherein the lipase is selected from the group consisting of plant lipase, animal lipase, bacterial lipase, and fungal lipase. 4 . The method of claim 2 , wherein the lipase is from carica papaya, porcine pancreas, Burkholderia cepacia, Pseudomonas cepacia, candida rugosa, rhizomucor miehei, aspergillus oryzae. 5 . The method of claim 2 , wherein the esterase is selected from the group consisting of thermophilic esterase APE1547, ethyl chrysanthemate esterase, esterase EST12-7, liver esterase, and carboxylesterase. 6 . The method of claim 1 , wherein the nitrogen-containing reagent is selected from the group consisting of ammonia water, urea, a basic ammonium salt, and thiourea. 7 . The method of claim 1 , wherein the biological enzyme is in the form of immobilized enzyme particles, enzyme powder, cells or organelles containing the biological enzyme, or crude enzymes obtained by culturing enzyme-producing microorganisms. 8 . The method of claim 1 , wherein the biological enzyme and the 3-isobutylglutarimide have a mass ratio of 1:1-1:20. 9 . The method of claim 8 , wherein the biological enzyme and the 3-isobutylglutarimide have a mass ratio of 1:5-1:10. 10 . The method of claim 1 , wherein the solvent is a miscible system of water and an organic solvent. 11 . The method of claim 10 , wherein the organic solvent is selected from the group consisting of ethanol, tetrahydrofuran, and acetone. 12 . The method of claim 10 , wherein the water and the organic solvent have a mass ratio of 1:1-1:5. 13 . The method of claim 1 , wherein the 3-isobutylglutarimide and the solvent have a mass ratio of 1:5-1:50. 14 . The method of claim 13 , wherein the 3-isobutylglutarimide and the solvent have a mass ratio of 1:5-1:10. 15 . The method of claim 1 , wherein the reacting the 3-isobutylglutarimide is at a temperature range from 25° C. to 55° C. 16 . The method of claim 15 , wherein the reacting the 3-isobutylglutarimide is at a temperature range from 30° C. to 45° C. 17 . The method of claim 1 , wherein the reacting the 3-isobutylglutarimide is for a time from 8 h to 20 h. 18 . The method of claim 17 , wherein the reacting the 3-isobutylglutarimide is for a time from 8 h to 20 h. 19 . The method of claim 1 further comprising reacting the (R)-3-(carbamoylmethyl)-5-methylhexanoic acid with bromine under basic conditions to produce pregabalin.

Assignees

Inventors

Classifications

  • containing a carboxyl group {including Peroxycarboxylic acids} · CPC title

  • C12P13/02Primary

    Amides, e.g. chloramphenicol {or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes (peptides C12P21/00 or C07K)} · CPC title

  • Formation of amino groups in compounds containing carboxyl groups · CPC title

  • C07C227/06Primary

    by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2021114970A1 cover?
A method for preparing pregabalin chiral intermediate (R)-3-(carbamoylmethyl)-5-methylhexanoic acid by a biological enzyme method. In particular, the method comprises: reacting compound (I) 3-isobutylglutaric acid, as a raw material, with a nitrogen-containing agent to produce compound (II) 3-isobutylglutarimide; and performing stereoselective ring-opening of compound (II) under the action of a…
Who is the assignee on this patent?
Zhejiang Huahai Pharm Co Ltd
What technology area does this patent fall under?
Primary CPC classification C12P13/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Apr 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).